Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Brooklyn News: A Greenpoint Housing Lottery Launches
Lottery Opens for Greenpoint Stabilized Units With Views, Central Air, Starting at $410 a Month
A lottery has opened for apartments in a 100 percent affordable building going up on the waterfront in Greenpoint. The 22-story, 375-unit development is part
